My Member
Message Center
trending topics
market reports
-
Visit MEDICAL JAPAN 2023 TOKYO and take full advantage of the business opportunities!
2023-09-01
-
US to distribute 400 million free N95 masks at CVS, Walgreens in COVID fight
2022-01-21
-
Ethiopia receives additional 2.2 mln doses of Chinese-donated COVID-19 vaccines
2022-01-21
-
Hong Kong researchers say they develop novel material able to kill COVID-19 virus
2022-01-14
-
10 million more Chinese doses on way for Kenya
2022-01-14
-
Sino-African ties on track for a brighter future
2022-01-07
-
Efforts urged to boost COVID-19 vaccine production capacity in poor countries
2022-01-07
-
UAE approves Sinopharm's new protein-based COVID-19 vaccine
2022-01-07
-
UAE approves Sinopharm's new protein-based COVID-19 vaccine
2022-01-07
-
Zimbabwe buoyed by Chinese jabs
2021-12-31
-
Anti-depression drug fluvoxamine can prevent deterioration of mild COVID-19 infections
None of the 80 infected subjects who received fluvoxamine treatment for 15 days experienced deterioration in their health, while six persons in the placebo group all suffered deterioration, according to the research.
2020-12-16 -
New AI tool could make breast cancer treatment less expensive and more readily available
Imagine being a doctor and having a precocious resident permanently by your side, giving you brilliant insight into disease and helping you to identify the best treatment path for your patients.
2020-12-14 -
China's centralized drug-procurement program provides cheaper medicines
Fifty-five types of medicine listed in China's third-round centralized drug-procurement program have become available in public hospitals across the country at much lower prices, the National Healthcare Security Administration said Thursday.
2020-12-04 -
Eye health education platform to focus on medics, public
An eye health medical personnel incubating institute worked with an online medical care resources platform to give momentum to China's eye health industry and raise it to an international level.
2020-12-03 -
Sinopharm submits market approval application for COVID vaccine
Leading COVID-19 vaccine developer Sinopharm has submitted a market approval application to China's top market regulator, Xinhua News Agency quoted the company's deputy general manager Shi Shengyi as saying on Wednesday.
2020-12-01 -
Company took lead in virus testing
Shortly after China reported increased cases of COVID-19 in early January, researchers at a company based in Guangzhou, capital of Guangdong province, quickly turned to developing a nucleic acid detection kit.
2020-11-20 -
Ministry: Five Chinese COVID-19 vaccines in clinical trials
Five Chinese COVID-19 vaccine candidates are in Phase III clinical trials in foreign countries including the United Arab Emirates, Brazil, Pakistan and Peru, Foreign Ministry spokesman Zhao Lijian said on Wednesday.
2020-11-19 -
Driving digital health in India
India offers a great market opportunity for healthcare start-ups around the world. With over 1.3 billion population majority of people pay for healthcare expenses out-of-pocket.
2020-11-18 -
Report finds 88% coverage rate in rehab services for disabled in 2019
More than 8.1 million disabled Chinese received subsidized rehabilitative services in 2019, ranging from artificial cochlea implantation for the hearing-impaired to psychological consultations for people with intellectual disabilities, a report said.
2020-11-17 -
Pfizer, BioNTech announce COVID-19 vaccine candidate over 90 percent effective
Pfizer and BioNTech expect to produce globally up to 50 million vaccine doses in 2020 and up to 1.3 billion doses in 2021.
2020-11-10